Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: Comparison with positron emission tomography using 18F-fluorodeoxyglucose

Journal of the American College of Cardiology

Volumn 32, Issue 4, 1998, Pages 927-935

  Matsunari, Ichiro ^a   Böning, Guido ^a   Ziegler, Sibylle I ^a   Nekolla, Stephan G ^a   Stollfuss, Jens C ^a   Kosa, Istvan ^a   Ficaro, Edward P ^b   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HEART; HEART CONTRACTION; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING;

AGED; AGED, 80 AND OVER; CORONARY DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032173449     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00340-4     Document Type: Article

References (42)

1. Rahimtoola S. The hibernating myocardium. Am Heart J. 117:1989;211-221.
2. Tillisch J., Brunken R., Marshall R., et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 314:1986;884-888.
3. Tamaki N., Yonekura Y., Yamashita K., et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol. 64:1989;860-865.
4. Knuuti M.J., Nuutila P., Ruotsalainen U., et al. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J Nucl Med. 34:1993;2068-2075.
5. vom-Dahl J., Eitzman D.T., Al-Aouar Z.R., et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation. 90:1994;2356-2366.
6. Tamaki N., Kawamoto M., Tadamura E., et al. Prediction of reversible ischemia after revascularization Perfusion and metabolic studies with positron emission tomography . Circulation. 91:1995;1697-1705.
7. Dilsizian V., Bonow R.O. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation. 87:1993;1-20.
8. Dilsizian V., Rocco T.P., Freedman N.M., Leon M.B., Bonow R.O. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 323:1990;141-146.
9. 18F-fluorodeoxyglucose . Circulation. 83:1991;26-37.
10. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 87:1993;1630-1641.
11. Kahn J.K., McGhie I., Akers M.S., et al. Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile a direct comparison in normal individuals and patients with coronary artery disease . Circulation. 79:1989;1282-1293.
12. Higley B., Smith F.W., Smith T., et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent . J Nucl Med. 34:1993;30-38.
13. 99mTc-sestamibi . Circulation. 89:1994;2552-2561.
14. 18F]fluorodeoxyglucose . Circulation. 89:1994;578-587.
15. Matsunari I., Fujino S., Taki J., et al. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med. 36:1995;1961-1967.
16. Kauffman G.J., Boyne T.S., Watson D.D., Smith W.H., Beller G.A. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol. 27:1996;1592-1597.
17. 99mTc sestamibi in patients undergoing cardiac transplantation a scintigraphic/pathological study . Circulation. 94:1996;1010-1017.
18. Matsunari I., Fujino S., Taki J., et al. Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization comparison with rest-redistribution thallium-201 . J Am Coll Cardiol. 29:1997;1226-1233.
19. Altehoefer C., vom-Dahl J., Biedermann M., et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability comparison with fluorine-18-FDG PET . J Nucl Med. 35:1994;569-574.
20. Rossetti C., Landoni C., Lucignani G., et al. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease. Eur J Nucl Med. 22:1995;1306-1312.
21. Sawada S.G., Allman K.C., Muzik O., et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol. 23:1994;92-98.
22. Soufer R., Dey H.M., Ng C.K., Zaret B.L. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol. 75:1995;1214-1219.
23. Bacharach S., Buvat I. Attenuation correction in cardiac positron emission tomography and single-photon emission computed tomography. J Nucl Cardiol. 2:1995;246-255.
24. King M., Tsui B., Pan T. Attenuation compensation for cardiac single-photon emission computed tomographic imaging: part 1 Impact of attenuation and methods of estimating attenuation maps . J Nucl Cardiol. 2:1995;513-524.
25. 99mTc-sestamibi single-photon emission computed tomography . Circulation. 93:1996;463-473.
26. Matsunari B. I, öning G., Ziegler S.I., et al. Attenuation-corrected rest thallium-201/stress technetium-99m sestamibi myocardial SPECT in normals. J Nucl Cardiol. 5:1998;48-55.
27. Matsunari B. I, öning G., Ziegler S.I., et al. Effects of misalignment between transmission and emission scans on attenuation-corrected cardiac SPECT. J Nucl Med. 39:1998;411-416.
28. Fessler J. Penalized weighted least-squares image reconstruction for positron emission tomography. IEEE Trans Med Imaging. 13:1994;290-300.
29. Baer F.M., Voth E., Deutsch H.J., et al. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol. 28:1996;60-69.
30. Chan R.K., Lee K.J., Calafiore P., Berlangieri S.U., McKay W.J., Tonkin A.M. Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol. 27:1996;1601-1607.
31. Ficaro E.P., Fessler J.A., Ackermann R.J., Rogers W.L., Corbett J.R., Schwaiger M. Simultaneous transmission-emission thallium-201 cardiac SPECT effect of attenuation correction on myocardial tracer distribution . J Nucl Med. 36:1995;921-931.
32. 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group . Circulation. 91:1995;313-319.
33. Platts E.A., North T.L., Pickett R.D., Kelly J.D. Mechanism of uptake of technetium-tetrofosmin I. uptake into isolated adult rat ventricular myocytes and subcellular localization . J Nucl Cardiol. 2:1995;317-326.
34. 201Tl in a model of acute coronary reperfusion. Circulation. 94:1996;2605-2613.
35. Matsunari I., Fujino S., Taki J., et al. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease. Am J Cardiol. 77:1996;350-354.
36. Duvernoy C., von Dahl J., Laubenbacher C., Schwaiger M. The role of nitrogen 13 ammonia positron emission tomography in predicting functional outcome after coronary revascularization. J Nucl Cardiol. 2:1995;499-506.
37. Marinho N.V.S., Keogh B.E., Costa D.C., Lammerstma A.A., Ell P.J., Camici P.G. Pathophysiology of chronic left ventricular dysfunction New insights from the measurement of absolute myocardial blood flow and glucose utilization . Circulation. 93:1996;737-744.
38. Gerber B.L., Vanoverschelde J.L.J., Bol A., et al. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction implications for the pathophysiology of chronic myocardial hibernation . Circulation. 94:1996;651-659.
39. Sansoy V., Glover D.K., Watson D.D., et al. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Circulation. 92:1995;994-1004.
40. Wackers F.J.T. Radionuclide detection of myocardial ischemia and myocardial viability is the glass half empty or half full (editorial)? J Am Coll Cardiol. 27:1996;1598-1600.
41. Koplan B., Beller G., Ruiz M., Yang J., Watson D., Glover D. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction. J Nucl Med. 37:1996;1398-1402.
42. vom Dahl J., Altehoefer C., Sheehan F.H., et al. Recovery of regional left ventricular dysfunction after coronary revascularization impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography . J Am Coll Cardiol. 28:1996;948-958.